Electroconvulsive Therapy in Transgender and Gender Diverse Population: A Case Report and Review of Literature.

Q4 Medicine

Case Reports in Psychiatry Pub Date : 2024-05-07 eCollection Date: 2024-01-01 DOI:10.1155/2024/5552781

Lachlan Draper, Ashis Vikas, Subhash Das, Suresh Yadav, Frances Walker, Ivona Bandilovska

{"title":"Electroconvulsive Therapy in Transgender and Gender Diverse Population: A Case Report and Review of Literature.","authors":"Lachlan Draper, Ashis Vikas, Subhash Das, Suresh Yadav, Frances Walker, Ivona Bandilovska","doi":"10.1155/2024/5552781","DOIUrl":null,"url":null,"abstract":"Objective: Present a case of a transgender and gender diverse (TGD) individual receiving gender affirming hormone therapy (GAHT) who presented with first episode bipolar mania and received electroconvulsive therapy (ECT). To understand the safety and efficacy of ECT in the TGD population including those receiving GAHT through literature review.Materials and methods: Case report using informed consent from an individual TGD patient who received ECT. A review of the literature was conducted using PubMed, Embase, and Medline.Results: The case illustrated safe and effective ECT use in a TGD individual receiving GAHT. Eight studies were reviewed. GAHT has been reported to interfere with certain anaesthetic agents used in ECT. ECT appeared to be a safe and effective treatment in the TGD samples in those studies.Conclusion: There is limited literature on the safety and efficacy of ECT for TGD individuals receiving GAHT. More research is required to address mental health inequalities in this population and to support safe and effective gender affirming treatment modalities.","PeriodicalId":9631,"journal":{"name":"Case Reports in Psychiatry","volume":"2024 ","pages":"5552781"},"PeriodicalIF":0.0000,"publicationDate":"2024-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11093682/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Case Reports in Psychiatry","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2024/5552781","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

Abstract

Objective: Present a case of a transgender and gender diverse (TGD) individual receiving gender affirming hormone therapy (GAHT) who presented with first episode bipolar mania and received electroconvulsive therapy (ECT). To understand the safety and efficacy of ECT in the TGD population including those receiving GAHT through literature review.

Materials and methods: Case report using informed consent from an individual TGD patient who received ECT. A review of the literature was conducted using PubMed, Embase, and Medline.

Results: The case illustrated safe and effective ECT use in a TGD individual receiving GAHT. Eight studies were reviewed. GAHT has been reported to interfere with certain anaesthetic agents used in ECT. ECT appeared to be a safe and effective treatment in the TGD samples in those studies.

Conclusion: There is limited literature on the safety and efficacy of ECT for TGD individuals receiving GAHT. More research is required to address mental health inequalities in this population and to support safe and effective gender affirming treatment modalities.

查看原文本刊更多论文

变性和性别多元化人群的电休克疗法：病例报告和文献综述。

目的：介绍一例接受性别平权激素疗法（GAHT）的变性人和性别多元化（TGD）患者首次发作躁狂症并接受电休克疗法（ECT）的病例。通过文献综述，了解电休克疗法在 TGD 群体（包括接受 GAHT 治疗者）中的安全性和有效性：病例报告使用了一名接受电休克疗法的 TGD 患者的知情同意书。使用PubMed、Embase和Medline对文献进行了回顾：结果：该病例说明在一名接受 GAHT 的 TGD 患者身上使用 ECT 是安全有效的。回顾了八项研究。有报告称 GAHT 会干扰 ECT 中使用的某些麻醉剂。在这些研究中，对豚鼠样本进行电痉挛疗法似乎是一种安全有效的治疗方法：有关接受 GAHT 的 TGD 患者接受电痉挛疗法的安全性和有效性的文献有限。需要开展更多研究，以解决这一人群的心理健康不平等问题，并支持安全有效的性别平权治疗模式。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊